Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1995;92:3229-3234

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heidenreich, P. A.
Right arrow Articles by Cheitlin, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heidenreich, P. A.
Right arrow Articles by Cheitlin, M. D.

(Circulation. 1995;92:3229-3234.)
© 1995 American Heart Association, Inc.


Articles

Pericardial Effusion in AIDS

Incidence and Survival

Paul A. Heidenreich, MD; Mark J. Eisenberg, MD; Laura L. Kee, RN MSN; Carolyn A. Somelofski, MSN; Harry Hollander, MD; Nelson B. Schiller, MD; Melvin D. Cheitlin, MD

From the Division of Cardiology, University of California, San Francisco, and San Francisco (Calif) General Hospital (C.A.S., M.D.C.).

Correspondence to Paul Heidenreich, MD, Department of Cardiology, Box 0124, 505 Parnassus Ave, San Francisco, CA 94143-0124. E-mail heiden@cardio.ucsf.edu.

Background Although pericardial effusion is known to be common among patients infected with HIV, the incidence of pericardial effusion and its relation to survival have never been described.

Methods and Results To evaluate the incidence of pericardial effusion and its relation to mortality in HIV-positive subjects, 601 echocardiograms were performed on 231 subjects recruited over a 5-year period (inception cohort: 59 subjects with asymptomatic HIV, 62 subjects with AIDS-related complex, and 74 subjects with AIDS; 21 HIV-negative healthy gay men; and 15 subjects with non-HIV end-stage medical illness). Echocardiograms were performed every 3 to 6 months (82% had follow-up studies). Sixteen subjects were diagnosed with effusions (prevalence of effusion for AIDS subjects entering the study was 5%). Thirteen subjects developed effusions during follow-up; 12 of these were subjects with AIDS (incidence, 11%/y). The majority of effusions (80%) were small and asymptomatic. The survival of AIDS subjects with effusions was significantly shorter (36% at 6 months) than survival for AIDS subjects without effusions (93% at 6 months). This shortened survival remained significant (relative risk, 2.2, P=.01) after adjustment for lead time bias and was independent of CD4 count and albumin level.

Conclusions There is a high incidence of pericardial effusion in patients with AIDS, and the presence of an effusion is associated with shortened survival. The development of an effusion in the setting of HIV infection suggests end-stage HIV disease (AIDS).


Key Words: pericardium • AIDS • heart diseases • echocardiography




This article has been cited by other articles:


Home page
J. Clin. Microbiol.Home page
S. Jinno, T. Jirakulaporn, M. J. Bankowski, W. Kim, and R. Wong
Rare Case of Nocardia asteroides Pericarditis in a Human Immunodeficiency Virus-Infected Patient
J. Clin. Microbiol., July 1, 2007; 45(7): 2330 - 2333.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
P. D. Corr
Imaging of cerebrovascular and cardiovascular disease in AIDS patients.
Am. J. Roentgenol., July 1, 2006; 187(1): 236 - 241.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
C. S. Restrepo, L. Diethelm, J. A. Lemos, E. Velasquez, T. A. Ovella, S. Martinez, J. Carrillo, and D. F. Lemos
Cardiovascular Complications of Human Immunodeficiency Virus Infection
RadioGraphics, January 1, 2006; 26(1): 213 - 231.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Y. Hsue and D. D. Waters
What a Cardiologist Needs to Know About Patients With Human Immunodeficiency Virus Infection
Circulation, December 20, 2005; 112(25): 3947 - 3957.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Ntsekhe and J. Hakim
Impact of Human Immunodeficiency Virus Infection on Cardiovascular Disease in Africa
Circulation, December 6, 2005; 112(23): 3602 - 3607.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. J. Dosios, N. P. Theakos, D. C. Angouras, O. I. Katsarou, and P. J. Asimacopoulos
AIDS-related cardiac tamponade: Is surgical drainage justified?
Ann. Thorac. Surg., September 1, 2004; 78(3): 1084 - 1085.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
G Permanyer-Miralda
Acute pericardial disease: approach to the aetiologic diagnosis
Heart, March 1, 2004; 90(3): 252 - 254.
[Full Text] [PDF]


Home page
HeartHome page
B D Prendergast
HIV AND CARDIOVASCULAR MEDICINE
Heart, July 1, 2003; 89(7): 793 - 800.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
D Nzuobontane, K N Blackett, and C Kuaban
Cardiac involvement in HIV infected people in Yaounde, Cameroon
Postgrad. Med. J., November 1, 2002; 78(925): 678 - 681.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Barbaro
Cardiovascular Manifestations of HIV Infection
Circulation, September 10, 2002; 106(11): 1420 - 1425.
[Full Text] [PDF]


Home page
HeartHome page
G. BARBARO, S. D FISHER, A. M PELLICELLI, and S. E LIPSHULTZ
The expanding role of the cardiologist in the care of HIV infected patients
Heart, October 1, 2001; 86(4): 365 - 367.
[Full Text] [PDF]


Home page
JRSMHome page
G. Barbaro
Cardiovascular manifestations of HIV infection
J R Soc Med, January 8, 2001; 94(8): 384 - 390.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. M. Pellicelli, G. Barbaro, F. Palmieri, E. Girardi, C. D'Ambrosio, A. Rianda, G. Barbarini, D. Frigiotti, M. C. Borgia, and N. Petrosillo
Primary Pulmonary Hypertension in HIV Patients: A Systematic Review
Angiology, January 1, 2001; 52(1): 31 - 41.
[Abstract] [PDF]


Home page
Eur Heart JHome page
J.J. Monsuez, B. Gallet, L. Escaut, F. Vayre, J.C. Charniot, M. Pulik, M Merad, C. Minozzi, M. Slama, S. Weber, et al.
Clinical outcome after coronary events in patients treated with HIV-protease inhibitors
Eur. Heart J., December 2, 2000; 21(24): 2079 - 2080.
[PDF]


Home page
Arch Intern MedHome page
Y. Chen, D. Brennessel, M. Johnson, F. Rosner, P. Rerkpattanapipat, N. Wongpraparut, L. E. Jacobs, and M. N. Kotler
Pericardial Effusion in Acquired Immunodeficiency Disease
Arch Intern Med, August 14, 2000; 160(15): 2397 - 2398.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
P. Rerkpattanapipat, N. Wongpraparut, L. E. Jacobs, and M. N. Kotler
Cardiac Manifestations of Acquired Immunodeficiency Syndrome
Arch Intern Med, March 13, 2000; 160(5): 602 - 608.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. Silva-Cardoso, B. Moura, L. Martins, A. Mota-Miranda, F. Rocha-Goncalves, and H. Lecour
Pericardial Involvement in Human Immunodeficiency Virus Infection
Chest, February 1, 1999; 115(2): 418 - 422.
[Abstract] [Full Text] [PDF]


Home page
Journal Watch CardiologyHome page
Pericardial Effusion in AIDS: A Grim Sign
Journal Watch Cardiology, February 1, 1996; 1996(201): 16 - 16.
[Full Text]


Home page
JWatch GeneralHome page
PERICARDIAL EFFUSION IN AIDS: A GRIM SIGN
Journal Watch (General), December 15, 1995; 1995(1215): 2 - 2.
[Full Text]